Comparative performance of the human papillomavirus test and cytology for primary screening for high‐grade cervical intraepithelial neoplasia at the population level

Study of the Risks of CIN3+ detection following multiple rounds of HPV testing: Results of the 15‐year cervical cancer screening experience at Kaiser Permanente Northern California.

(2020) Anne Hammer et al.   INTERNATIONAL JOURNAL OF CANCER

Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project

(2020) Francesca Holme et al.   PREVENTIVE MEDICINE

Meta‐analysis of the accuracy of p16 or p16/Ki‐67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology

(2019) Eliana Peeters et al.   CANCER CYTOPATHOLOGY

Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs

(2018) Kate Cuschieri et al.   INTERNATIONAL JOURNAL OF CANCER

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months

(2018) Gina Suzanne Ogilvie et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

(2018) Marc Arbyn et al.   BMJ-British Medical Journal

Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women

(2017) Murat Gultekin et al.   INTERNATIONAL JOURNAL OF CANCER

Optimizing secondary prevention of cervical cancer: Recent advances and future challenges

(2017) Gina Ogilvie et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial

(2016) Sandra D. Isidean et al.   INTERNATIONAL JOURNAL OF CANCER

Immediate referral to colposcopy versus cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature

(2016) Maria Kyrgiou et al.   INTERNATIONAL JOURNAL OF CANCER

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

(2015) Darrel A. Cook et al.   BMC CANCER

World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer

(2015) Nancy Santesso et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years

(2015) Ellinor Östensson et al.   PLoS One

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2

(2014) Philip E. Castle et al.   OBSTETRICS AND GYNECOLOGY

How distressing is referral to colposcopy in cervical cancer screening?

(2013) Ida J. Korfage et al.   GYNECOLOGIC ONCOLOGY

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial

(2011) Eduardo Lazcano-Ponce et al.   LANCET

How to evaluate emerging technologies in cervical cancer screening?

(2009) Marc Arbyn et al.   INTERNATIONAL JOURNAL OF CANCER

Decreasing Cervical Cancer Mortality in Mexico: Effect of Papanicolaou Coverage, Birthrate, and the Importance of Diagnostic Validity of Cytology

(2008) E. Lazcano-Ponce et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION